Sign in
Taking peopleNo phase

Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Online Mindfulness-Based Cognitive Therapy

Key facts

Who runs it
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
42 people, planned
Started
26 Aug 2026
Expected to end
Nov 2028
Type of study
Interventional
Treatments tested
  • Mindfulness-based Cognitive Therapy for OCD
Record updated
25 September 2026

Who can take part

Age
18 years to 45 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 24 criteriaShow less

Who can take part

  • Diagnosis of obsessive-compulsive disorder (OCD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • Age between 18 and 45 years
  • Stable pharmacological treatment for at least 3 months prior to the start of the experimental intervention
  • No previous experience with mindfulness meditation, or previous mindfulness meditation experience with no practice during the 12 months prior to study enrollment
  • Ability and willingness to provide written informed consent
  • Age between 18 and 45 years, with age matching within a maximum difference of ±3 years from the corresponding index patient. In all cases, control participants must be at least 18 years and no older than 48 years
  • Voluntary participation in the study
  • Ability and willingness to provide written informed consent

Who cannot take part

  • Previous mindfulness meditation practice within the 12 months prior to study enrollment
  • Current or previous mindfulness meditation practice within the 12 months prior to study enrollment
  • Diagnosis of schizophrenia spectrum or other psychotic disorders, including schizoaffective disorder
  • Diagnosis of bipolar and related disorders
  • Major depressive disorder in an acute phase
  • Active substance use disorder or alcohol use disorder as the primary diagnosis
  • Personality disorders of clinically significant severity
  • Documented major neurocognitive disorder. Neurological conditions or medical conditions with a clinically significant impact on cognitive or mental functioning
  • History of psychiatric disorders, as assessed using the Structured Clinical Interview for DSM-5 Disorders - Clinician Version (SCID-CV)
  • Intellectual developmental disorder
  • Current substance use disorder or alcohol use disorder
  • Neurological disorders, including Parkinson's disease, major neurocognitive disorders, neurodegenerative syndromes, ataxias, multiple sclerosis, cerebrovascular events (stroke or transient ischemic attack [TIA]), central nervous system neoplasms, epilepsy, history of seizures, or clinically significant tremor
  • Systemic medical conditions (e.g., diabetes mellitus, atherosclerosis, chronic arterial hypertension, or malignancies) requiring pharmacological treatment
  • Age younger than 18 years
  • Inability or unwillingness to provide informed consent; Healthy subjects

Other criteria

  • Patients with OCD

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study has two main objectives: (1) to evaluate the acceptability and feasibility of a specialized Mindfulness-Based Cognitive Therapy (MBCT) program for Obsessive-Compulsive Disorder (OCD), delivered via videoconference in a synchronous group format; and (2) to explore the associations between selected clinical and biological markers, OCD severity, and treatment response.

Read full original descriptionShow less

This is an interventional study involving outpatients with a diagnosis of OCD recruited at two participating centers in Italy: IRCCS Fatebenefratelli in Brescia (Center 1) and Centro Terapia Cognitiva e Mindfulness per il DOC in Vicenza (Center 2). Participants will take part in group-based treatment based on the MBCT program for OCD.

Participants recruited at Center 1 will undergo blood and saliva sampling for the molecular analyses planned as part of the study. A healthy control group, matched for age and sex, will also be recruited for comparison in the analyses related to the second objective.

The group in the trial

  • Mindfulness-Based Cognitive Therapy (MBCT) for OCDTreatment being tested

    Participants will receive a manualized Mindfulness-Based Cognitive Therapy (MBCT) program for obsessive-compulsive disorder (OCD), integrating cognitive-behavioral therapy, exposure techniques, mindfulness, decentering, acceptance, and self-compassion practices.

    Treatment: Mindfulness-based Cognitive Therapy for OCD

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Implementation of an Integrated, Manualized Group Mindfulness-Based Cognitive Therapy Intervention
Criteria questions
Built from NCT07834567, who can take part
Record updated
25 September 2026